News
-
-
-
-
-
-
-
PRESS RELEASE
Atos Group: new strategic and transformation plan “Genesis” to leverage core strengths and restore sustainable profitable growth. Cash generation and disciplined capital allocation as key drivers to deleveraging
Atos Group unveils 'Genesis' plan to drive growth, profitability, and AI focus through strategic restructuring, capable leadership, and innovative investments -
PRESS RELEASE
Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial -
-